Back in 2009, Jeremy and Lila Stewart returned from Jakarta Indonesia to Dallas with an idea for a company with a heart. As entrepreneurs, they perceived the need for premium sandals that were comfortable and came in more colors than variations on black and brown. They also chose a beneficiary, pediatric cancer patients. Today, you know their company as Hari Mari and the beneficiary as Flops Fighting Cancer.
Hari Mari comes from Hari – sun in Indonesian and Mari – (mare) sea in Latin. These flops are made for fun in the sun and on the water. They’re constructed with premium materials – leather, densely woven cotton and high-test nylon for long life, and come in rainbow colors with intensities ranging from pastels to neon. Made with carbon-free rubber outsoles, they’re non-marking, boat safe, and help improve grip on wet surfaces. For added comfort, they offer additional toe lift, beveled outsole edges and their own memory foam toe posts that reduce toe abrasion and do away with uncomfortable break-in periods.
Made with high grade recyclable rubber and foam, Hari Mari works to keep used flips out of landfills. Their Zero Landfill initiative allows customers to send in their used flip flops of any brand for repurposing and recycling. Repurposing includes working with international philanthropic partners like Soles4Soles to get sandals to people in need of footwear around the world, before they are considered for recycling.
Hari Mari’s Flops Fighting Cancer program helps support children battling pediatric cancer. Cancer is the most common fatal disease striking children. It is more deadly than cystic fibrosis, pediatric AIDS and diabetes, combined. Hari Mari gives $3 for every pair sold to Flops Fighting Cancer. The program helps pay for expensive medical treatments, medicines and hospital costs for families-in-need.
On Saturday, August 2nd, you’ll have a chance to meet our Hari Mari rep at our Mockingbird store in Dallas. Please stop by between 11am to 3 pm to learn more about Hari Mari flops and Flops Fighting Cancer.